TD Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

TD Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-49,500	Closed	-$706K	–	1539
2020 Q4	$706K	Buy	+49,500	New	+$667K	﹤0.01%	1261
2020 Q3	–	Sell	-89,500	Closed	-$949K	–	1392
2020 Q2	$949K	Sell	89,500 -136,000	-60%	-$1.38M	﹤0.01%	1073
2020 Q1	$1.82M	Sell	225,500 -464,000	-67%	-$3.87M	﹤0.01%	857
2019 Q4	$5.6M	Hold	689,500	–	–	0.01%	690
2019 Q3	$5.22M	Hold	689,500	–	–	0.01%	675
2019 Q2	$5.17M	Hold	689,500	–	–	0.01%	679
2019 Q1	$5.58M	Buy	689,500 +640,500	+1,307%	+$4.87M	0.01%	664
2018 Q4	$369K	Buy	+49,000	New	+$345K	﹤0.01%	1280
2016 Q1	–	Sell	-23,000	Closed	-$213K	–	1380
2015 Q4	$213K	Sell	23,000 -60,000	-72%	-$657K	﹤0.01%	1298
2015 Q3	$1.06M	Buy	83,000 +54,500	+191%	+$677K	﹤0.01%	907
2015 Q2	$315K	Sell	28,500 -21,000	-42%	-$232K	﹤0.01%	1245
2015 Q1	$565K	Buy	49,500 +9,500	+24%	+$101K	﹤0.01%	1088
2014 Q4	$404K	Sell	40,000 -1,000	-2%	-$10.5K	﹤0.01%	1156
2014 Q3	$431K	Buy	+41,000	New	+$385K	﹤0.01%	1071

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TD Asset Management's RDY Position: Q1 2021 in Review

TD Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 49,500 shares — an estimated $706K sold.

TD Asset Management first reported a position in RDY in Q3 2014 and held it in 14 quarters. The position peaked at $5.6M in Q4 2019. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

TD Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
TD Asset Management sold 49,500 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $706K.
TD Asset Management first reported a position in Dr. Reddy's Laboratories in Q3 2014 and held it in 14 quarters.
TD Asset Management's Dr. Reddy's Laboratories position peaked at $5.6M in Q4 2019.
160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on TD Asset Management's 13F filing for Q1 2021, filed 14 May 2021.